| 0 |
Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] |
3 |
0.0288 |
| 1 |
Lymphocyte Activation Gene-3 Blocker [EPC] |
1 |
0.0019 |
| 2 |
Antimetabolite Immunosuppressant [EPC] |
36 |
0.0017 |
| 3 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
21 |
0.0009 |
| 4 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
10 |
0.0007 |
| 5 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
32 |
0.0007 |
| 6 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
46 |
0.0004 |
| 7 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
10 |
0.0004 |
| 8 |
Monobactam Antibacterial [EPC] |
1 |
0.0004 |
| 9 |
Antimalarial [EPC] |
2 |
0.0002 |
| 10 |
Antiprotozoal [EPC] |
2 |
0.0002 |
| 11 |
CD38-directed Cytolytic Antibody [EPC] |
1 |
0.0002 |
| 12 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
22 |
0.0002 |
| 13 |
Protease Inhibitor [EPC] |
7 |
0.0002 |
| 14 |
Glycopeptide Antibacterial [EPC] |
10 |
0.0002 |
| 15 |
Cytochrome P450 3A Inhibitor [EPC] |
9 |
0.0001 |
| 16 |
Antimycobacterial [EPC] |
3 |
0.0001 |
| 17 |
Lipopeptide Antibacterial [EPC] |
1 |
0.0001 |
| 18 |
Quinolone Antimicrobial [EPC] |
1 |
0.0001 |
| 19 |
Corticosteroid [EPC] |
127 |
0.0001 |
| 20 |
Human Immunoglobulin G [EPC] |
2 |
0.0001 |
| 21 |
Rifamycin Antibacterial [EPC] |
3 |
0.0001 |
| 22 |
Interleukin-17A Antagonist [EPC] |
3 |
0.0001 |
| 23 |
Nitroimidazole Antimicrobial [EPC] |
5 |
0.0001 |
| 24 |
Tetracycline-class Drug [EPC] |
5 |
0.0001 |
| 25 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
3 |
0.0001 |
| 26 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
5 |
0.0001 |
| 27 |
Nucleoside Analog Antiviral [EPC] |
4 |
0.0000 |
| 28 |
Androgen [EPC] |
1 |
0.0000 |
| 29 |
Integrin Receptor Antagonist [EPC] |
3 |
0.0000 |
| 30 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 31 |
Sympathomimetic-like Agent [EPC] |
1 |
0.0000 |
| 32 |
Interleukin-23 Antagonist [EPC] |
3 |
0.0000 |
| 33 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
3 |
0.0000 |
| 34 |
Azole Antifungal [EPC] |
4 |
0.0000 |
| 35 |
Pyrimidine Synthesis Inhibitor [EPC] |
1 |
0.0000 |
| 36 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
1 |
0.0000 |
| 37 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 38 |
Macrolide Antimicrobial [EPC] |
1 |
0.0000 |
| 39 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 40 |
Catecholamine [EPC] |
1 |
0.0000 |
| 41 |
Anti-IgE [EPC] |
1 |
0.0000 |
| 42 |
Nucleoside Metabolic Inhibitor [EPC] |
3 |
0.0000 |
| 43 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 44 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 45 |
Endothelin Receptor Antagonist [EPC] |
2 |
0.0000 |
| 46 |
Vitamin D [EPC] |
3 |
0.0000 |
| 47 |
Vitamin B12 [EPC] |
3 |
0.0000 |
| 48 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 49 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 50 |
Opioid Agonist [EPC] |
2 |
0.0000 |
| 51 |
Vitamin C [EPC] |
3 |
0.0000 |
| 52 |
CD20-directed Cytolytic Antibody [EPC] |
2 |
0.0000 |
| 53 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 54 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
7 |
0.0000 |
| 55 |
Expectorant [EPC] |
1 |
0.0000 |
| 56 |
Folate Analog Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 57 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 58 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
2 |
0.0000 |
| 59 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 60 |
Thalidomide Analog [EPC] |
1 |
0.0000 |